- Home
- PCVX vs SKT Comparison
PCVX vs SKT Comparison
Compare PCVX & SKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- SKT
- Stock Information
- Founded
- PCVX 2013
- SKT 1981
- Country
- PCVX United States
- SKT United States
- Employees
- PCVX N/A
- SKT N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- SKT Real Estate Investment Trusts
- Sector
- PCVX Health Care
- SKT Real Estate
- Exchange
- PCVX Nasdaq
- SKT Nasdaq
- Market Cap
- PCVX 4.0B
- SKT 3.9B
- IPO Year
- PCVX 2020
- SKT 1993
- Fundamental
- Price
- PCVX $45.93
- SKT $34.56
- Analyst Decision
- PCVX Strong Buy
- SKT Buy
- Analyst Count
- PCVX 7
- SKT 9
- Target Price
- PCVX $101.67
- SKT $37.00
- AVG Volume (30 Days)
- PCVX 1.3M
- SKT 849.6K
- Earning Date
- PCVX 11-04-2025
- SKT 11-04-2025
- Dividend Yield
- PCVX N/A
- SKT 3.40%
- EPS Growth
- PCVX N/A
- SKT 8.00
- EPS
- PCVX N/A
- SKT 0.94
- Revenue
- PCVX N/A
- SKT $575,140,000.00
- Revenue This Year
- PCVX N/A
- SKT $2.56
- Revenue Next Year
- PCVX N/A
- SKT $4.65
- P/E Ratio
- PCVX N/A
- SKT $36.60
- Revenue Growth
- PCVX N/A
- SKT 10.01
- 52 Week Low
- PCVX $27.66
- SKT $28.69
- 52 Week High
- PCVX $103.30
- SKT $37.57
- Technical
- Relative Strength Index (RSI)
- PCVX 63.80
- SKT 62.18
- Support Level
- PCVX $40.14
- SKT $33.22
- Resistance Level
- PCVX $45.90
- SKT $34.83
- Average True Range (ATR)
- PCVX 2.15
- SKT 0.80
- MACD
- PCVX -0.07
- SKT 0.19
- Stochastic Oscillator
- PCVX 98.26
- SKT 90.34
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.
About SKT Tanger Inc.
Tanger Inc is an owners and operators of outlet and open-air centers in the United States and Canada. It is a fully-integrated, self-administered and self-managed REIT, which focuses on developing, acquiring, owning, operating and managing outlet and open-air shopping centers. Its consolidated portfolio consisted of 31 outlet centers and 2 open-air lifestyle centers, with a total gross leasable area of approximately 13.0 million square feet.